Georgetown-Howard-MedStar GHUCCTS Receives $24.3 Million CTSA from NIH
Congratulations to the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) for receiving a $24.3 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Science (NCATS) from the NIH. This renewal marks the third 5-year award for GHUCCTS, which has secured close to $90 million in research funding for its member institutions.
GHUCCTS' mission is to advance research and training with excellence, innovation, collaboration, and efficiency and it's great news to share that we will be able to do just that while engaging our communities in clinical research.
Over the last 10 years, GHUCCTS has accomplished several goals including:
- created an academic home for clinical and translational scientists and trainees;
- stimulated an increase inresearch involving underserved populations
- provided training and education programs to support the full lifespan of an investigational career, including support for graduate students, post-doctoral fellows and junior faculty members;
- established a Master of Science degree program in Clinical and Translational Research, and supported another MS in Health Informatics and Data Science;
- established system-wide biostatistics and informatics capabilities;
- promoted team science and encouraged interdisciplinary research through pilot grants and novel technology cores;
- streamlined processes for initiation of research projects and reduced the regulatory burden for investigators by creating a single IRB for GHUCCTS institutions;
- engaged our communities to produce new partnerships between investigators in academia and community-based programs; and
- established an efficient local trial innovation team to partner with the CTSA Trial Innovation Network in order to speed completion of multi-center clinical trials that will get more treatments to more patients more quickly.
Comments
Post a Comment